Share
ISSN: 1665-2681
ANNALS OF HEPATOLOGY is an international open access journal published bimonthly and is funded by Medica Sur Clinical Foundation, Mexico City, Mexico. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin-American Association for the Study of the Liver (ALEH) and the Canadian Association for the Study of the Liver (CASL) and publishes original papers, concise reviews, letters to the Editor, invited editorials, opinions and viewpoints in the field of Hepatology.
ANNALS OF HEPATOLOGY'S main topics are alcoholic liver disease, viral hepatitis (HAV, HBV, HCV, HDV, HEV), NAFLD/NASH, genetic liver diseases, autoimmune hepatitis, drug¿induced liver injury and biliary diseases. The journal's aim is to publish articles focused on basic, clinic care and translational research that seeks to prevent rather than treat the complications of endstage liver disease.
Indexed in:
Scopus, Web of Science, Medline
See moreFollow us:
2.125 (2019)
1.895 (2018)
Impact Factor
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.
© Clarivate Analytics, Journal Citation Reports 2020
Impact Factor 2019
2.125
CiteScore 2019
CiteScore measures average citations received per document published. Read more
CiteScore 2019
3
SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.
SJR
0.64
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
SNIP
0.656
Hide
Issue
Pages 339-448 (July - August 2020)
Editorial
Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology
Marco Arrese
Ann Hepatol. 2020;19:339-40
Open access
Opinions
The imperative for an updated cirrhosis surgical risk score
Natalie Zhen Wong, Nadim Mahmud
Ann Hepatol. 2020;19:341-3
Open access
Concise reviews
Osteopontin – A potential biomarker of advanced liver disease
Radan Bruha, Libor Vitek, Vaclav Smid
Ann Hepatol. 2020;19:344-52
Open access
The liver in times of COVID-19: What hepatologists should know
Ezequiel Ridruejo, Alejandro Soza
Ann Hepatol. 2020;19:353-8
Open access
Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, Giovanni Targher
Ann Hepatol. 2020;19:359-66
Open access
Original articles
Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients
Kanako Kikukawa, Sawako Uchida-Kobayashi, Akihiro Tamori, Kanako Yoshida, Kohei Kotani, Hiroyuki Motoyama, Ritsuzo Kozuka, Atsushi Hagihara, Hideki Fujii, Hiroyasu Morikawa, Masaru Enomoto, Yoshiki Murakami, Norifumi Kawada
Ann Hepatol. 2020;19:367-72
Open access
Prevalence of NAFLD in Guatemala following exposure to a protein-energy nutrition intervention in early life
Ahlia Sekkarie, Siran He, Jean A. Welsh, Usha Ramakrishnan, Aryeh D. Stein, Miriam B. Vos
Ann Hepatol. 2020;19:373-9
Open access
Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?
Francesco Giuseppe Foschi, Marco Domenicali, Pierluigi Giacomoni, Anna Chiara Dall’Aglio, Fabio Conti, Alberto Borghi, Vittoria Bevilacqua, Lucia Napoli, Federica Mirici, Alessandro Cucchetti, Giorgio Ercolani, Andrea Casadei Gardini, Stefano Bellentani, Amalia Gastaldelli, Mauro Giuffrè, Claudio Tiribelli, Giorgio Bedogni
Ann Hepatol. 2020;19:380-7
Open access
Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B
Mauricio Lisker-Melman, Mandana Khalili, Steven H. Belle, Norah A. Terrault, Hsing-Hua S. Lin, Coleman I. Smith, Raymond T. Chung, Naoky Tsai, Natalie H. Bzowej, Tram T. Tran, Sarah Jane Schwarzenberg
Ann Hepatol. 2020;19:388-95
Open access
A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management
Julio D. Vorobioff, Fernando Contreras, Federico Tanno, Lucía Hernández, Fernando Bessone, Luis Colombato, José Adi, Eduardo Fassio, Mirta Felgueres, Guillermo Fernández, Luis Gaite, Diana Gibelli, Hernán Gómez Darrichon, Matías Lafage, Daniel Lombardo, Susana López, Alejandro Mateo, Manuel Mendizábal, Julieta Pecoraro, Andrés Ruf, Pablo Ruiz, Javier Severini, Teodoro Stieben, Marcela Sixto, Fabián Zárate, Sergio de la Barra Barraza, Irene Donoso Sierra, Violeta Rivas Pacheco, Juan P. Roblero, Juan O. Rojas, Patricio Ruiz González, Diego San Martín Rodríguez, Armando Sierralta, Alvaro Urzúa Manchego, Eliana Valdes, Pamela Yaquich, Rodrigo Wolff, Flor Beltran Valdivia, Roxana C. Gallegos, Rocío Galloso, Julio S. Marcelo, Pedro Montes, Laura Tenorio, Isabel Veramendi, Elizabeth Alava, Ximena Armijos, Gonzalo Benalcazar, Enrique Carrera, Galo F. Pazmiño, Eduardo Marriott Díaz, Miguel Garassini, Rosalía P. Marrero, Mirta Infante, Dayron Páez Suárez, José C. Gutiérrez, Carmen M. Villadoniga Reyes, Yoel M. Serrano, Rivardo Hernández Hernández, Orelvis Martínez Martínez, Teresita Pérez González, María T. Andara, Marco Sánchez Hernández, Solange Gerona, Iván García, Fátima de la Tijera, Edmundo Pessoa López, Kenia Torres, Martín Garzón
Ann Hepatol. 2020;19:396-403
Open access
Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: A nationwide survey (NHANES 2011–2016)
Debashis Reja, Michael Makar, Aayush Visaria, Briette Karanfilian, Vinod Rustgi
Ann Hepatol. 2020;19:404-10
Open access
Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway
Wenyue Zhang, Juan Huang, Yao Tang, Yixuan Yang, Huaidong Hu
Ann Hepatol. 2020;19:411-6
Open access
Platelets level variability during the first year after liver transplantation in the risk prediction model for recipients mortality
Wojciech Jarmulski, Alicja Wieczorkowska, Mariusz Trzaska, Ewa Hryniewiecka, Leszek Pączek, Michał Ciszek
Ann Hepatol. 2020;19:417-21
Open access
Viral eradication restores normal iron status in chronic hepatitis C patients with abnormal iron studies
Yazan Hasan, Kyle Brown
Ann Hepatol. 2020;19:422-6
Open access
The impact of different infectious complications on mortality of hospitalized patients with liver cirrhosis
Héctor Adrián Díaz-Hernández, Gerardo Vázquez-Anaya, Godolfino Miranda-Zazueta, Graciela Elia Castro-Narro
Ann Hepatol. 2020;19:427-36
Open access
Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America
Mayur Brahmania, Stephen Liu, Abdus S. Wahed, Colina Yim, Bettina E. Hansen, Mandana Khalili, Norah A. Terrault, Anna S. Lok, Marc Ghany, Junyao Wang, David Wong, Harry L.A. Janssen
Ann Hepatol. 2020;19:437-45
Open access
News
Special content about COVID-19
Publish in
Annals of Hepatology
Affiliated societies
